DENTSPLY SIRONA Inc. (NASDAQ:XRAY – Get Free Report) announced a quarterly dividend on Monday, December 15th. Investors of record on Friday, December 26th will be given a dividend of 0.16 per share by the medical instruments supplier on Friday, January 9th. This represents a c) dividend on an annualized basis and a yield of 5.6%. The ex-dividend date of this dividend is Friday, December 26th.
DENTSPLY SIRONA has increased its dividend payment by an average of 0.1%per year over the last three years and has increased its dividend annually for the last 13 consecutive years. DENTSPLY SIRONA has a payout ratio of 31.2% meaning its dividend is sufficiently covered by earnings. Analysts expect DENTSPLY SIRONA to earn $1.90 per share next year, which means the company should continue to be able to cover its $0.64 annual dividend with an expected future payout ratio of 33.7%.
DENTSPLY SIRONA Stock Down 0.3%
Shares of NASDAQ XRAY opened at $11.37 on Wednesday. The stock has a market capitalization of $2.27 billion, a P/E ratio of -2.57, a PEG ratio of 0.83 and a beta of 1.01. DENTSPLY SIRONA has a one year low of $9.85 and a one year high of $20.59. The firm’s 50 day simple moving average is $11.71 and its two-hundred day simple moving average is $13.67. The company has a debt-to-equity ratio of 1.36, a current ratio of 1.47 and a quick ratio of 0.99.
Wall Street Analysts Forecast Growth
Several equities research analysts have weighed in on XRAY shares. Robert W. Baird dropped their price target on shares of DENTSPLY SIRONA from $14.00 to $12.00 and set a “neutral” rating for the company in a research report on Tuesday. Barrington Research reiterated an “outperform” rating and set a $14.00 target price on shares of DENTSPLY SIRONA in a report on Tuesday. JPMorgan Chase & Co. lowered their price target on DENTSPLY SIRONA from $14.00 to $12.00 and set a “neutral” rating for the company in a research report on Friday, November 7th. Needham & Company LLC reiterated a “hold” rating on shares of DENTSPLY SIRONA in a research report on Friday, September 26th. Finally, UBS Group reduced their target price on DENTSPLY SIRONA from $24.00 to $23.00 and set a “buy” rating on the stock in a research note on Tuesday, October 28th. Two research analysts have rated the stock with a Buy rating, ten have issued a Hold rating and three have assigned a Sell rating to the company. According to MarketBeat, the company currently has an average rating of “Reduce” and a consensus target price of $15.15.
View Our Latest Stock Report on XRAY
About DENTSPLY SIRONA
DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.
Further Reading
- Five stocks we like better than DENTSPLY SIRONA
- Stock Splits, Do They Really Impact Investors?
- AI Chips Can’t Exist Without These 2 Underrated Tech Giants
- 3 REITs to Buy and Hold for the Long Term
- Why Taiwan Semiconductor’s 6.5% Dip Could Be a Smart Buy
- What Are Earnings Reports?
- RTX Surges to Record Highs as Defense Orders Explode
Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with MarketBeat.com's FREE daily email newsletter.
